Loading
A phase 2 trial of DT-7012 run by Gustave Roussy, Cancer Campus, Grand Paris, not yet recruiting.
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma is a phase 2 interventional study registered as NCT07802652 by Gustave Roussy, Cancer Campus, Grand Paris, with 80 participants planned, started 2027-02-01. Conditions recorded: Undifferentiated Pleomorphic Sarcoma (UPS) and Dedifferentiated Liposarcoma (DDLPS). Interventions recorded: DT-7012 and Doxorubicin.
Shares DT-7012, Kainova Therapeutics and the tag pipeline.
Shares DT-7012, Kainova Therapeutics and the tag pipeline.
Shares Kainova Therapeutics and the tag pipeline.
Shares Kainova Therapeutics and the tag pipeline.
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
Shares Undifferentiated pleomorphic sarcoma (UPS), Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/